Asset Management One’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-13,314
Closed -$551K 1033
2022
Q3
$551K Hold
13,314
﹤0.01% 877
2022
Q2
$794K Hold
13,314
﹤0.01% 859
2022
Q1
$966K Hold
13,314
﹤0.01% 857
2021
Q4
$1.1M Hold
13,314
﹤0.01% 860
2021
Q3
$1.2M Hold
13,314
﹤0.01% 842
2021
Q2
$1.27M Hold
13,314
﹤0.01% 844
2021
Q1
$1.52M Hold
13,314
0.01% 823
2020
Q4
$1.96M Hold
13,314
0.01% 786
2020
Q3
$1.09M Sell
13,314
-4,873
-27% -$400K 0.01% 828
2020
Q2
$1.42M Hold
18,187
0.01% 800
2020
Q1
$808K Hold
18,187
﹤0.01% 834
2019
Q4
$777K Hold
18,187
﹤0.01% 896
2019
Q3
$778K Hold
18,187
﹤0.01% 893
2019
Q2
$1.16M Sell
18,187
-18,449
-50% -$1.17M 0.01% 871
2019
Q1
$2.54M Buy
36,636
+5,706
+18% +$396K 0.01% 750
2018
Q4
$1.3M Sell
30,930
-421
-1% -$17.7K ﹤0.01% 837
2018
Q3
$2.5M Sell
31,351
-6,982
-18% -$557K 0.01% 796
2018
Q2
$2.92M Sell
38,333
-10,206
-21% -$777K 0.01% 800
2018
Q1
$2.48M Hold
48,539
0.01% 801
2017
Q4
$2.28M Hold
48,539
0.01% 832
2017
Q3
$2.62M Hold
48,539
0.01% 814
2017
Q2
$3M Buy
48,539
+7,320
+18% +$453K 0.01% 760
2017
Q1
$2.77M Buy
41,219
+17,600
+75% +$1.18M 0.01% 760
2016
Q4
$1.66M Buy
23,619
+2,602
+12% +$183K ﹤0.01% 784
2016
Q3
$1.44M Buy
21,017
+17,435
+487% +$1.2M 0.02% 722
2016
Q2
$177K Buy
+3,582
New +$177K ﹤0.01% 1213